智通财经APP获悉，复宏汉霖(02696)早盘涨超8%，截至发稿，涨8.56%，报64.8港元，成交额2010.27万港元。
消息面上，近日，据复宏汉霖官微消息，公司宣布，公司商业合作伙伴Getz Pharma (Private) Limited(“Getz Pharma”)收到相关注册证书，复宏汉霖自主开发和生产的汉达远®(阿达木单抗)获得巴基斯坦药监局(Drug Regulatory Authority of Pakistan, DRAP)批准上市，商品名为Adaliget®，获批原研阿达木单抗在当地的所有适应症。
汉达远®成为继汉曲优®(曲妥珠单抗，欧洲商品名：Zercepac®，美国商品名：HERCESSI®)、H药汉斯状®(斯鲁利单抗，欧洲商品名：Hetronifly®)、汉倍优®(帕妥珠单抗，欧美商品名：Poherdy®)和汉贝泰®(贝伐珠单抗)等产品后，复宏汉霖第八款海外获批上市的产品。汉达远®已于2026年7月被纳入中国《国家基本药物目录(2026年版)》。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.